
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
A review of the best ads of 2004--and the people that created them.
over 21 years ago
Elephant or Specialist?over 21 years ago
Global Report: Iron Fistover 21 years ago
Washington Report: The Pendulum Swingsover 21 years ago
What Does It Take to be a Global Leader in Trainingover 21 years ago
Unleash the Tabletsover 21 years ago
Eisai's New Leadershipover 21 years ago
Superstar Selectionover 21 years ago
TOCover 21 years ago
Professional Persuasion:101over 21 years ago
Out to Lunch?





